Clinical Trials Logo

Chronic Obstructive Pulmonary Disease clinical trials

View clinical trials related to Chronic Obstructive Pulmonary Disease.

Filter by:

NCT ID: NCT01933984 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients

Start date: August 2013
Phase: N/A
Study type: Interventional

This study evaluates whether individualized dosing schedule of inhaled bronchodilator is more effective than fixed dosing in reducing airway resistance of intubated COPD patients.

NCT ID: NCT01933308 Terminated - COPD Clinical Trials

Optimization of Pulmonary Rehabilitation Programmes: the OPTION Study

OPTION
Start date: November 2008
Phase: N/A
Study type: Interventional

Chronic obstructive pulmonary disease (COPD) has a profound impact on the lives of individuals who suffer from it. Participants with COPD are often caught in a downward spiral that goes from chronic airflow limitation to invalidity and poor quality of life. Exercise training is considered the key to successful pulmonary rehabilitation (PR) because it is responsible for much of the benefits associated with this intervention. However, despite current guidelines recommend high-intensity exercise training. the optimal exercise training protocol for PR participants has yet to be determined. Aims: The main goal of the proposed research project will be to determine the optimal exercise training protocol in PR. More specifically, the objectives will be to compare the effects of continuous high-intensity training (CT80), continuous training at the ventilatory threshold (CTVT), and interval training (IT) on various PR program outcomes and to compare participant compliance to the three training regimens. Methods: One hundred and twenty subjects will be recruited. Participants who meet the eligibility criteria and accept to participate in the study will be randomized to one of three groups: the CT80 group, the CTVT group, or the IT group. Session duration will be adjusted such that the total amount of work performed per session will be comparable between the three groups. Assessments will be made at baseline (week 0), at program completion (week 12), and one year after program start (year 1). The primary outcome measure will be short-term (12 weeks) change in exercise tolerance, as measured by the endurance time to constant-load cycling. Secondary outcome measures will include: long-term (1 year) change in exercise tolerance; short-term and long-term changes in functional status, psychological status, cognition, and health-related quality of life; average participant compliance to the target intensity throughout the 12-week program; and long-term adherence to exercise recommendations. Relevance: The proposed research will inform clinicians and scientists regarding which of the exercise training protocols currently used in PR is optimal for COPD participants by examining their short-term and long-term impact on physiological, functional, psychological, neuropsychological, behavioural and quality of life outcomes. For COPD participants, our findings have the potential to improve the effectiveness of a key intervention for the management of their disease.

NCT ID: NCT01931644 Completed - Breast Cancer Clinical Trials

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Start date: July 2013
Phase:
Study type: Observational

We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.

NCT ID: NCT01930526 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Single Leg Cycling in COPD: Knowledge Translation to Pulmonary Rehabilitation

Start date: July 2011
Phase: N/A
Study type: Interventional

Pulmonary rehabilitation (PR) with supervised exercise training is a key part of care for patients with chronic lung disease (COPD). Patients can improve their shortness of breath, walking distance and quality of life. However, many patients do not improve their overall fitness. They are too breathless to train at a high enough intensity. In a laboratory training study, patients with COPD improved their overall fitness by using single leg cycling. Despite this knowledge, single leg cycling has not been used clinically. The objective of this project is to use and assess single leg cycling in a clinical setting. Single leg cycling can be incorporated into a clinical service (replacing traditional two legged cycling) as the predominant aerobic training strategy, resulting in improvements in cardio-respiratory fitness (peak oxygen uptake).

NCT ID: NCT01927172 Not yet recruiting - Asthma Clinical Trials

AirSonea Wheeze Detection Study

Start date: September 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the AirSonea device provides an objective assessment of breath sounds for the presence of wheeze in both medical and home environments.

NCT ID: NCT01926275 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

NPPV Added Inspiratory Muscle Training in Severe COPD

Start date: July 2013
Phase: N/A
Study type: Interventional

The aim of this study is to determine whether noninvasive positive pressure ventilation with inspiratory muscle training can improve quality of life and respiratory muscle strength than noninvasive positive pressure ventilation or inspiratory muscle training alone.

NCT ID: NCT01922271 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

FAST
Start date: August 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is to further figure out differences of glycopyrronium bromide compared to tiotropium in early bronchodilation measured by a comprehensive assessment of lung function that includes hyperinflation and specific airway resistance in patients with moderate to severe COPD.

NCT ID: NCT01921712 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients

Start date: July 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of PUR0200. In addition, the study will look at the blood levels of different doses of PUR0200 and their affect on lung function in COPD patients.

NCT ID: NCT01921556 Active, not recruiting - COPD Clinical Trials

The Improving Care in Chronic Obstructive Lung Disease Study A Cluster Randomized Trial

CAROL
Start date: September 2013
Phase: N/A
Study type: Interventional

Background The Swiss health ministry launched a national quality program "QualiCCare" in 2011 to improve healthcare for patients with COPD. The aim of this study is to determine whether participation in the COPD quality initiative ("QualiCCare") improves adherence to recommended clinical processes and shows impact on patients COPD care and on quality of life in patients with COPD.

NCT ID: NCT01921127 Completed - COPD Clinical Trials

Comparative Effectiveness of Symbicort vs. Advair Among COPD Patients

Start date: August 2013
Phase: N/A
Study type: Observational

This study is intended to evaluate treatment effectiveness of BFC compared to FSC in COPD patients new to ICS/LABA combination therapy.